Pharmaceutical Industry Blog

Last Updated: July 17, 2026 TL;DR: Yemen — a nation of more than 41 million people whose health system is being sustained and rebuilt under great strain, running from referral and teaching hospitals in Sana'a, Aden, Taiz, Hodeidah and Mukalla down to governorate hospitals, district hospitals and primary health-care units, and which imports the large majority of its finished medicines and almost all of its active pharmaceutical ingredients — depends on a reliable, compliant su

Last Updated: July 17, 2026 TL;DR: Afghanistan — a nation of more than 43 million people whose health system is being rebuilt and sustained across a large, mountainous, landlocked territory, running from national and regional hospitals in Kabul, Herat, Mazar-i-Sharif, Kandahar and Jalalabad down to provincial hospitals and thousands of basic and comprehensive health centres, and which imports more than 95% of its medicines and almost all of its active pharmaceutical ingredien

Last Updated: July 16, 2026 TL;DR: Argentina — a nation of more than 45 million people with one of Latin America's strongest and most self-sufficient pharmaceutical industries, a founding member of Mercosur and home to ANMAT, a PAHO/WHO reference regulatory authority — depends on a reliable, compliant supply of the specialty and critical-care injectables it needs, together with active pharmaceutical ingredients and technology-transfer partners. Every imported sterile injectab

Last Updated: July 16, 2026 TL;DR: Iraq — a nation of more than 47 million people whose health system is rebuilding across federal governorates and the Kurdistan Region, running from teaching hospitals in Baghdad, Basra, Mosul and Erbil down to general and district hospitals and primary health centres, and which imports the large majority of its finished pharmaceuticals and almost all of its active pharmaceutical ingredients — depends on a reliable, compliant supply of steril

Last Updated: July 16, 2026 TL;DR: Algeria — the largest country in Africa by area and a nation of more than 47 million people, with one of North Africa's biggest pharmaceutical markets and a strong, state-backed drive toward local production — depends on a reliable, compliant supply of sterile injectables and specialty products it does not yet make at home, together with active pharmaceutical ingredients and technology-transfer partners. Every imported sterile injectable mus

Last Updated: July 16, 2026 TL;DR: Uganda — a nation of more than 51 million people whose health system runs from national referral hospitals in Kampala down to regional referral, district and rural facilities across every region, and which imports the large majority of its finished pharmaceuticals and almost all of its active pharmaceutical ingredients — depends on a reliable, compliant supply of sterile injectables. Every imported sterile injectable must be registered with